Entasis Therapeutics Holdings Inc. (ETTX), relating to its proposed acquisition by Innoviva, Inc. Under the terms of the agreement, ETTX shareholders will receive $2.20 in cash per share they own.
Entasis Therapeutics Holdings Inc. (ETTX), relating to its proposed acquisition by Innoviva, Inc. Under the terms of the agreement, ETTX shareholders will receive $2.20 in cash per share they own.